Chinese AI Startup Moonshot Valued at $50 Billion Ahead of Hong Kong IPO
Chinese AI startup Moonshot AI has achieved a $50 billion valuation and plans a $5 billion Hong Kong IPO in Q1 next year, targeting rapid annual revenue growth.
Chinese artificial intelligence startup Moonshot AI has closed a funding round valuing the company at $50 billion and is planning an initial public offering (IPO) on the Hong Kong Stock Exchange in the first quarter of next year, according to a Bloomberg report citing sources familiar with the matter.
IPO Preparation and Fundraising Goals
Sources noted that the company has begun preparing to gauge investor interest through preliminary meetings, which could kick off as early as this month. Last month, the firm behind the Kimi chatbot submitted a confidential prospectus for a Hong Kong listing. The upcoming IPO is considered one of the most anticipated transactions in Hong Kong, where AI industry fundraising is breaking new records. Sources, who spoke on condition of anonymity, stated that Moonshot is considering raising up to $5 billion in the IPO.
Moonshot is regarded as one of the rising stars of the Chinese AI scene. It burst onto the global stage in July with the launch of its open model Kimi K3, which competes head-to-head in certain benchmarks with leading platforms from companies such as OpenAI and Anthropic. The company's valuation has risen steadily through a series of funding rounds; a previous round in July valued the firm at $31.5 billion.
Financial Projections and Market Challenges
According to insiders, Moonshot's annual recurring revenue (ARR) is projected to reach $2 billion by December, up from $1 billion currently. The company hit $300 million in ARR in June. However, it remains unclear how tightened government oversight of the Chinese AI industry might impact the valuation or the IPO timeline. Discussions are ongoing, and the timing could change. Moonshot did not immediately respond to a request for comment.
"Moonshot AI was founded in early 2023 by Yang Zhilin, a former Tsinghua University professor who previously worked at Meta and Google. Investors include Alibaba, Tencent, and 5Y Capital."
Last week, the company sparked controversy when it was revealed that it is conducting an internal review after researchers successfully persuaded two Kimi models to provide instructions for creating biological weapons and carrying out assassinations.
